Company news
MedMira Inc. news in 2022
MedMira Inc.'s news releases, calls and decks from 2022, newest first.
MedMira Reports First Quarter Results FY2023
December 30, 2022
MedMira Introduces VYRA TriDemic
December 29, 2022
MedMira Reports FY2021 Fourth Quarter and Year End Financial Results
November 29, 2022
MedMira Receives CE Mark for Its VYRA(TM) COVID-19 Antigen Test
October 14, 2022
MedMira provides Progress Update
October 3, 2022
MedMira Strengthens and Expands Board
July 14, 2022
MedMira Reports Third Quarter Results FY2022
June 29, 2022
MedMira Receives Patent for its Unique Quantitative Diagnostic System
June 6, 2022
MedMira provides an update on the new In Vitro Diagnostic Medical Devices Regulation (IVDR) in the European Market
May 27, 2022
MedMira receives CE mark for Multiplo® Complete Syphilis (TP/nTP) Antibody Test
May 12, 2022
MedMira receives the CE mark for its Reveal TP (Syphilis) and starts clinical trials in Canada
March 10, 2022
MedMira receives the CE mark for its Reveal® TP (Syphilis) and starts clinical trials in Canada
March 9, 2022
MedMira Receives CE Marking for its REVEALCOVID-19 PLUS Total Antibody Test
February 9, 2022
MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test
February 8, 2022
MedMira Provides a Pre-Annual General Meeting Update
February 4, 2022